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Abstract
Background: Colloidal silver has been used as an antimicrobial and disinfectant agent. However, there is scarce
information on its antitumor potential. The aim of this study was to determine if colloidal silver had cytotoxic
effects on MCF-7 breast cancer cells and its mechanism of cell death.
Methods: MCF-7 breast cancer cells were treated with colloidal silver (ranged from 1.75 to 17.5 ng/mL) for 5 h at
37°C and 5% CO2 atmosphere. Cell Viability was evaluated by trypan blue exclusion method and the mechanism of
cell death through detection of mono-oligonucleosomes using an ELISA kit and TUNEL assay. The production of
NO, LDH, and Gpx, SOD, CAT, and Total antioxidant activities were evaluated by colorimetric assays.
Results: Colloidal silver had dose-dependent cytotoxic effect in MCF-7 breast cancer cells through induction of
apoptosis, shown an LD50 (3.5 ng/mL) and LD100 (14 ng/mL) (*P < 0.05), significantly decreased LDH (*P < 0.05)
and significantly increased SOD (*P < 0.05) activities. However, the NO production, and Gpx, CAT, and Total
antioxidant activities were not affected in MCF-7 breast cancer cells. PBMC were not altered by colloidal silver.
Conclusions: The present results showed that colloidal silver might be a potential alternative agent for human
breast cancer therapy.
Background
Prior to 1938, colloidal silver was widely used to prevent
or treat numerous diseases. Its use decreased with the
development of antibiotics, such as penicillin and sulfani-
lamide [1]. However, since 1990 there has been a resur-
gence on the use of colloidal silver as an alternative
medicine because of increased resistance of bacteria to
antibiotics, and the continuing search for novel and
affordable antimicrobial agents. Colloidal silver is a sus-
pension of submicroscopic metallic silver particles of
about 0.001 microns in size, the presence of particles
results in the overall increased surface area [2,3]. Colloi-
dal silver has been used as disinfectant of foods and
water in Mexico; it acts by disabling the oxygen metabo-
lism enzymes in bacteria, which ultimately kills microor-
ganisms. In vitro evidence has shown that bacterial
isolates of Escherichia coli and Staphylococcus aureus are
highly susceptible to colloidal silver treatment [4].
Although the use of colloidal silver as an antimicrobial
agent is recognized [4], there are scarce reports on its use
as antitumor agent; among these, there is a recent report
on the anti-proliferative effect of silver nanoparticles on
human glioblastoma cells (U251) in vitro [5]. Cancer is
an important cause of mortality worldwide and the num-
ber of people who are affected is increasing, being the
breast cancer one of the major causes of death in women
[6]. The origin of cancer cells can be related to metabolic
alteration, such as mitochondrial increase of glycolysis,
which largely depends on this metabolic pathway needed
to convert glucose into pyruvate, for the generation of
ATP to meet cancer cell energy needs. Many cancer cell
types produce ATP by conversion of glucose to lactate
and exhibit lower oxidative phosphorylation, and acceler-
ated glycolysis ensures ATP levels compatible with the
demands of fast proliferating tumor cells in a hypoxic
environment [7,8]. Furthermore, many reports have
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produced by the generation of reactive oxygen intermedi-
ates (ROI) in tumor cells, which increases the cytotoxicity
activity of the drugs [9]; the oxidative stress is a loss of
balance between ROI production and intracellular anti-
oxidants such as superoxide dismutase (SOD), catalase
(CAT), glutathione peroxidase (Gpx), and extracellular
antioxidants.
Although there is a wide range of cytotoxic agents used
in the treatment of breast cancer, such as doxorubicin,
cisplatin, and bleomycin, they have shown drawbacks in
their use and are not as efficient as expected [10]. There-
fore, it is of great interest to find novel therapeutic agents
against cancer. Hence, we evaluated the effects of colloi-
dal silver on MCF-7 human breast cancer cells growth.
Methods
Main reagents
Penicillin-streptomycin solution, ficoll-hypaque solution,
trypsin-EDTA solution, RPMI-1640 medium, Dulbecco’s
modified Eagle’s medium (DMEM/F-12), and 1% antibio-
tic-antimycotic solution were obtained from (Life Tech-
nologies GIBCO, Grand Island, NY, USA). Fetal bovine
serum (FBS) was purchased from Sigma-Aldrich (St.
Louis, MO).
Cell Culture
MCF-7 human breast cancer cell line was purchased
from American Type Culture Collection (ATCC, Mana-
ssas, VA, USA) and was maintained in Dulbecco’s modi-
fied Eagle’s medium supplemented with 10% fetal
bovine serum (FBS) and 1% antibiotic-antimycotic solu-
tion. Cells were grown to confluence at 37°C, and 5%
CO2 atmosphere.
Isolation of peripheral blood mononuclear cells (PBMC)
Blood from healthy human volunteers was obtained
with heparinized syringes and was placed into sterile
polypropylene tubes. PBMC were further isolated by
hystopaque 1077 density gradient centrifugation at 400
g for 30 min at 25°C (Sigma-Aldrich, St. Louis MO,
USA). PBMC were then washed twice with FBS-free
medium (RPMI-1640) at 250 g for 10 min at 25°C and
adjusted to 5 × 10
3 cells/well for analysis.
Colloidal silver
The grenetine-stabilized colloidal silver was purchased
from MICRODYN (Mexico, D.F.) as a 0.35% stock solu-
tion. It was filtered and diluted to a concentration of
1.75 ng/mL with DMEM/F-12 or RPMI-1640 medium.
Cell viability
Cells (5 × 10
3 cells/well) were plated on 96 flat-bottom
well plates, and incubated 24 h at 37°C in 5% CO2
atmosphere. After incubation, culture medium was
removed, and colloidal silver diluted in the same med-
ium was added at concentrations ranging from 1.75 to
17.5 ng/mL. The plates were then incubated for 5 h at
37°C, and 5% CO2 atmosphere. Thereafter, the superna-
tant was removed and cells were washed twice with
DMEM/F-12 medium. Cell viability was determined by
the trypan blue exclusion method, and cytotoxicity was
expressed as the concentration of 50% (LD50)a n d1 0 0 %
(LD100) cell growth inhibition. Results were given as the
mean + SD of three independent experiments.
Mechanism of cell death analysis
Cell death type was assessed by the detection of mono-
oligonucleosomes (histone-associated DNA fragments)
using an ELISA kit (Cell Death Detection ELISA PLUS,
Roche Applied Science, IN, USA) following the manufac-
turer’s instructions. In brief, the cytoplasmic lysates from
untreated controls and colloidal silver treated cultures
were transferred to a streptavidin-coated plate supplied by
the manufacturer. A mixture of anti-histone biotin and
anti DNA-POD were added to cell lysates and incubated
for 2 h. The complex was conjugated and then the plate
was read at a wavelength of 405 nm. The increase in
mono-oligonucleosomes production in cells lysates was
calculated as the ratio of the absorbance of colloidal silver
treated cells/absorbance of untreated control. Results were
given as the mean + SD of three independent experiments.
Tunel
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) was performed with TACS 2
TdT-DAB In Situ Apoptosis Detection kit (Trevigen,
Gaithersburg, Maryland, USA), following the manufac-
turer’s instructions. Briefly, after culture MCF-7 cells at
10
6 cells/well and treated with LD50 and LD100, by 5 h, the
cells were digested with proteinase K at a concentration of
20 μg/mL for 15 minutes. Endogenous peroxidase activity
was quenched with 2% H2O2 for 5 minutes. The cells were
immersed in terminal deoxynucleotidyl transferase (TdT)
buffer. TdT, 1 mM Mn
2+, and biotinylated dNTP in TdT
buffer were then added to cover the cells and incubated in
a humid atmosphere at 37°C for 60 minutes. The cells
were washed with PBS and incubated with streptavidin-
horseradish peroxidase for 10 minutes. After rinsing with
PBS, the cells were immersed in DAB solution. The cells
were counterstained for 3 minutes with 1% methyl green.
Cells containing fragmented nuclear chromatin character-
istic of apoptosis will exhibit brown nuclear staining that
may be very dark after labeling.
Detection of lactate dehydrogenase (LDH) activity
The conversion of lactate to pyruvate was detected using
the Cytotoxicity Detection Lactate Dehydrogenase kit
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facturer’s instructions. MCF-7 breast cancer cells and
PBMC treated with colloidal silver were washed twice
with ice-cold PBS, harvested by centrifugation at 250 g
for 10 min at 25°C, and the supernatant was used for
the activity assay according to the manufacturer’s
instructions. Optical densities resulting from LDH activ-
ity were measured in a microplate reader at 490 nm.
Results were given as the mean + SD of three indepen-
dent experiments.
Nitrite determination
Accumulation of nitrite in the supernatants of control
and treated MCF-7 and PBMC cultures was used as an
indicator of nitric oxide production. Cells were incubated
for 5 h in DMEM/F-12 medium, in the presence or
absence of colloidal silver in triplicates, in a total volume
of 200 μL DMEM/F-12 medium. After incubation, super-
natants were obtained and nitrite levels were determined
with the Griess reagent, using NaNO2 as standard. Opti-
cal densities at 540 nm were then determined in a micro-
plate reader (Bio-Tek Instruments, Inc.).
Determination of intracellular antioxidants
The antioxidants production was measured using the
following kits: Cellular glutathione peroxidase (Gpx)
assay kit (Oxford Biomedical Research, MI, USA), super-
oxide dismutase (SOD) assay kit (Cayman Chemical
Company, MI, USA), and catalase (CAT) assay kit (Cay-
man Chemical Company, MI, USA) according to the
manufacturer’s instructions. Briefly, to determine the
activity of Gpx, SOD, and CAT; MCF-7 and PBMC
were incubated with LD50 (3.5 ng/mL) and LD100 (14
ng/mL) of colloidal silver for 5 h. Cells were then
washed three times with PBS and sonicated on ice in a
bath-type ultrasonicador (80 Watts output power) for
15-s periods for a total of 4 min; the solution was then
centrifuged at 1500 g for 5 min at 4°C. The obtained
supernatants were used to determine intracellular anti-
oxidants in a microplate reader at 540 nm.
Total antioxidant (extracellular antioxidants)
The total antioxidant production was determined using
the Total Antioxidant Colorimetric Assay Kit (US Bio-
logical, Massachussets, USA) following manufacturer’s
instructions. Briefly, MCF-7 and PBMC were treated
with LD50 (3.5 ng/mL) and LD100 (14 ng/mL) of colloi-
dal silver for 5 h. Thereafter, supernatants were used
to determine antioxidants in a microplate reader at
490 nm.
Statistical analysis
Data represent the mean + SD of triplicates from three
independent experiments. Statistical differences were
obtained using the analysis of variance, and the Dun-
nett’s and Turkey’s tests (SPSS v. 12 program).
Results
Cytotoxic activity of colloidal silver on MCF-7 human
breast cancer cells
As observed in Figure 1, colloidal silver induced dose-
dependent cytotoxic effect on MCF-7 breast cancer
cells; the median lethal dose was (LD50) 3.5 ng/mL and
t h el e t h a ld o s e( L D 100) was 14 ng/mL (*P < 0.05). In
contrast, colloidal silver treatment did not affect PBMC
viability (Figure 1). These LD50 and LD100 were used in
further experiments.
Colloidal silver induced apoptosis in MCF-7 breast
cancer cells
The colloidal silver induced the mechanism of cell death
through apoptosis in MCF-7 human breast cancer cell
line, determined by the detection of mono-oligonucleo-
somes. The effects of LD50 and LD100 in control cells
only caused non-significant cytotoxicity of 3.05% (P <
0.05), respectively (Figure 2). The TUNEL technique
was also used to detect apoptosis. Labeling of DNA
strand breaks in situ by TUNEL demonstrated positive
cells that were localized in MCF-7 cells treated with
LD50 and LD100 and control, with increased cell apopto-
sis in the LD50 and LD100 (Figure 3).
Figure 1 Cell viability of MCF-7 cell line and PBMC treated with
colloidal silver. Cells (5 × 10
3 cells/well) were plated on 96 flat-
bottom well plates, and incubated 24 h at 37°C in 5% CO2
atmosphere. After incubation, culture medium was removed, and
colloidal silver diluted in the same medium was added at
concentrations ranging from 1.75 to 17.5 ng/mL. The plates were
then incubated for 5 h at 37°C, and 5% CO2 atmosphere. Thereafter,
the supernatant was removed and cells were washed twice with
DMEM/F-12 medium. Cell viability was determined by the trypan
blue exclusion method, and cytotoxicity was expressed as the
concentration of 50% (LD50) and 100% (LD100) cell growth
inhibition. The experiments were performed in triplicates; data
shown represent mean + SD of three independent experiments.
*P < 0.05 as compared with untreated cells.
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dehydrogenase in MCF-7 and PBMC
The lactate dehydrogenase activity significantly (*P <
0.05) decreased in MCF-7 and PBMC treated with col-
loidal silver LD50 and LD100 concentrations. Colloidal
silver-treated MCF-7 LD50 and LD100 were 1.918 U/mL
and 0.464 U/mL, respectively; untreated MCF-7 cells
value was 1.966 U/mL. Similarly, colloidal silver-treated
PBMC LD50 and LD100 concentrations were 0.964 U/mL
and 0.796 U/mL, respectively; compared with the
untreated PBMC value of 1.025 U/mL (Figure 4).
Effect of colloidal silver on nitric oxide production in
MCF-7 and PBMC
Figure 5 shows that NO production was undetectable (*P
< 0.05) in untreated PBMC, and in colloidal silver-treated
PBMC at LD50 and LD100 concentrations. However, in
untreated MCF-7 cells, nitrites concentration was 1.67
μM, but the colloidal silver-treated MCF-7 at LD50 and
LD100 did not affect NO production (*P < 0.05).
Effect of colloidal silver on intracellular and extracellular
antioxidants in MCF-7 and PBMC
The superoxide dismutase activity was significantly (*P <
0.05) increased in colloidal silver-treated MCF-7 at LD50
(13.54 U/mL) and LD100 (14.07 U/mL) concentrations,
compared with untreated control cells (10.37 U/mL),
which also significantly (*P < 0.05) increased in colloidal
silver-treated PBMC at LD50 (15.92 U/mL) and LD100
(16.032 U/mL) concentrations, compared with untreated
PBMC (12.458 U/mL) (Figure 6). However, the catalase,
glutathione peroxidase, and total antioxidant activities in
MCF-7 and PBMC treated with colloidal silver did not
differ significantly (*P < 0.05) from those of controls
(Figure 7).
Discussion
Woman breast cancer is the most important cause of mor-
tality in the world [6]. Nowadays, some cytotoxic agents
are used for its treatment including doxorubicin, daunoru-
bicin, bleomycin, and cisplatin. However, they are costly
and known to induce several side effects such as myelo-
suppression, anemia, and most importantly the generation
of cellular resistance. For this, it is important to find alter-
native therapies or drugs to overcome these drawbacks
[10]. Our in vitro studies showed that colloidal silver
induced a dose-dependent cell death in MCF-7 breast can-
cer cell line through apoptosis, without affecting the viabi-
lity of normal PBMC control cells. Most studies are
focused on the effect of colloidal silver on bacterial
growth, and the present study might contribute to the
comprehension of this compound on cancer therapy.
It has been known that cancer cells increased the rate of
glycolysis; in this metabolic pathway lactate dehydrogenase
is involved in catalyzing the conversion of pyruvate into
lactate, which consumes NADH and regenerates NAD
+
[8]. In the present study, we showed that MCF-7 breast
cancer cells treated with colloidal silver, significantly
reduced the dehydrogenase activity, resulting in decreased
NADH/NAD
+, which in turn induces cell death due to
decreased mitochondrial membrane potential. Death cell
can also be produced by ROI (Reactive Oxygen Intermedi-
ates), and RNI (Reactive Nitrogen Intermediate) metabo-
lites. Our results demonstrated that nitric oxide
production was not affected by colloidal silver treatments,
as compared with untreated cells (*P < 0.05), suggesting
that the MCF-7 breast cancer cell death was independent
of nitric oxide production. In addition, it was observed
that colloidal silver did not affect the catalase and glu-
tathione peroxidase activities (*P < 0.05). However, the
colloidal silver treatment increased superoxide dismutase
activity compared with untreated MCF-7 and PBMC (*P <
0.05). This may cause a redox imbalance, significantly
increasing the SOD activity in response to the production
of high levels of ROI molecules and the lack of activity of
catalase and glutathione peroxidase may allow the toxic
effect of hydrogen peroxide (H2O2) leading to cell death
[10]. The H2O2 causes cancer cells to undergo apoptosis,
pyknosis, and necrosis. In contrast, normal cells are con-
siderably less vulnerable to H2O2.T h er e a s o nf o rt h e
increased sensitivity of tumor cells to H2O2 is not clear
but may be due to lower antioxidant defenses. In fact, a
lower capacity to destroy H2O2 e.g., by catalase, peroxire-
doxins, and GSH peroxidases may cause tumor cells to
grow and proliferate more rapidly than normal cells in
response to low concentrations of H2O2. It is well known
that H2O2 exerts dose-dependent effects on cell function,
from growth stimulation at very low concentrations to
growth arrest, apoptosis, and eventually necrosis as H2O2
Figure 2 Apoptosis mediated by colloidal silver on MCF-7 cell
line. MCF-7 cells were treated with increasing concentrations of
colloidal silver (1.75 to 17.5 ng/mL) for 5 h. Thereafter, the levels of
mono-oligo nucleosome fragments were quantified using the Cell
Death Detection Kit. The experiments were performed in triplicates;
data shown represent mean + SD of three independent
experiments. *P < 0.05 as compared with untreated cells.
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Page 4 of 7Figure 3 MCF-7 cells stained by the TUNEL technique, counterstained with methyl green.( a) MCF-7 control, showing few brown staining
of cells (arrows). (b) MCF-7 treated with colloidal silver LD50 (c) and LD100 showing abundant brown staining of cells (arrows). Original
magnifications, a, b, and c:4 0× .
Figure 4 Effect of colloidal silver on LDH activity in MCF-7 cells
and PBMC. LDH activity was measured by changes in optical
densities due to NAD
+reduction which were monitored at 490 nm,
as described in the text, using the Cytotoxicity Detection Lactate
Dehydrogenase kit. The experiments were performed in triplicates;
data shown represent mean + SD of three independent
experiments. *P < 0.05 as compared with untreated cells.
Figure 5 Nitric oxide production in colloidal silver-treated
MCF-7 and PBMC. Nitric oxide production at 5 h by colloidal silver-
treated MCF-7 and PBMC, was measured using the nitric oxide
colorimetric assay kit, as described in methods. The experiments
were performed in triplicates; data shown represent mean + SD of
three independent experiments. *P < 0.05 as compared with
untreated cells.
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shifted to the left in tumor cells, making them more sensi-
tive to both the growth stimulatory and cytotoxic effects
of H2O2. Whatever the exact mechanism, the increased
sensitivity of tumor cells to killing by H2O2 may provide
the specificity and “therapeutic window” for the antitumor
therapy [11]. Colloidal silver is a common substance used
by the Mexican people for disinfecting foods and water for
their consumption, and at this time there is not a report
on potential secondary effects related to this treatment;
this also agreed with a recent study in mice performed in
our laboratory, where colloidal silver was provided in the
water at 10- and 50-fold higher concentrations than the
recommended by the manufacturer during one year with-
out finding any alterations in the evaluated parameters
(fertility, birth, and tumors development) (data not
shown). However, more studies are needed to elucidate
the mechanism of colloidal silver action, with the aim of
developing new strategies for the treatment of cancer and
other illness, with lower cost and effectiveness. Therefore,
it can be suggested that colloidal silver treatment may be
used as an alternative treatment against cancer. However,
the mechanism and pathways by which colloidal silver
induced cytotoxic activity on MCF-7 human breast cancer
cell line need further investigation.
Conclusions
The overall results indicated that the colloidal silver has
antitumor activity through induction of apoptosis in
MCF-7 breast cancer cell line, suggesting that colloidal
Figure 6 Superoxide dismutase activity in colloidal silver-
treated MCF-7 and PBMC. MCF-7 breast cancer cells and PBMC
were treated with colloidal silver for 5 h and then evaluated for
superoxide dismutase (SOD) activity, as explained in methods. The
experiments were performed in triplicates; data shown represent
mean + SD of three independent experiments. *P < 0.05 as
compared with untreated cells.
Figure 7 Effect of the colloidal silver on the intracellular and extracellular antioxidants. MCF-7 breast cancer cells and PBMC were treated
with colloidal silver for 5 h and the antioxidants production were measured as described in methods, using colorimetric assay kits. a) Gpx
activity, b) Catalase activity, c) Total antioxidant production. The experiments were performed in triplicates; data shown represent mean + SD of
three independent experiments. *P < 0.05 as compared with untreated cells.
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breast cancer therapy.
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